| Bos taurus |
Carbonic anhydrase IV |
IC50 |
100000.0 |
nM |
10.1021/jm030912m |
| Chlorocebus sabaeus |
Vero C1008 |
CC50 |
3920.0 |
nM |
10.6019/CHEMBL4495565 |
| Equus caballus |
Ferritin light chain |
Potency |
44668.4 |
nM |
None |
| Escherichia coli K-12 |
Endonuclease 4 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Bloom syndrome protein |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Bromodomain-containing protein 4 |
Delta TM |
-1.21 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Carbonic anhydrase I |
IC50 |
100000.0 |
nM |
10.1021/jm030912m |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
100000.0 |
nM |
10.1021/jm030912m |
| Homo sapiens |
Carbonic anhydrase IX |
IC50 |
100000.0 |
nM |
10.1021/jm030912m |
| Homo sapiens |
Casein kinase I delta |
Delta TM |
0.03 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Delta TM |
1.23 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Cyclooxygenase-1 |
Activity |
-0.2 |
% |
10.1021/jm201687d |
| Homo sapiens |
Cyclooxygenase-1 |
Activity |
0.1 |
% |
10.1016/j.bmc.2013.10.006 |
| Homo sapiens |
Cyclooxygenase-1 |
Activity |
0.2 |
% |
10.1021/jm201687d |
| Homo sapiens |
Cyclooxygenase-1 |
Activity |
12.4 |
% |
10.1016/j.bmc.2013.10.006 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
7.0 |
nM |
10.1021/jm960803q |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
7.8 |
nM |
10.1016/j.ejmech.2010.10.035 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
8.0 |
nM |
10.1021/acsmedchemlett.1c00065 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
8.9 |
nM |
10.1016/j.bmc.2013.01.058 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
9.0 |
nM |
10.1021/jm201528b |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
10.0 |
nM |
10.1021/np100057y |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
53.0 |
nM |
10.1021/acs.jmedchem.6b01484 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
160.0 |
nM |
10.1021/jm201528b |
| Homo sapiens |
Cyclooxygenase-1 |
Inhibition |
57.8 |
% |
10.1021/jm0580149 |
| Homo sapiens |
Cyclooxygenase-1 |
Inhibition |
61.3 |
% |
10.1021/np900374s |
| Homo sapiens |
Cyclooxygenase-1 |
Inhibition |
95.1 |
% |
10.1016/j.bmcl.2006.02.021 |
| Homo sapiens |
Cyclooxygenase-1 |
Inhibition |
nan |
% |
10.1007/s00044-009-9168-x |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
1030.0 |
nM |
10.1021/acsmedchemlett.1c00004 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
3300.0 |
nM |
10.1016/j.ejmech.2019.07.016 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
6300.0 |
nM |
10.1021/jm201528b |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.6b01484 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
55600.0 |
nM |
10.1021/acsmedchemlett.1c00065 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
74900.0 |
nM |
10.1021/jm960803q |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
10.1016/j.bmc.2012.03.021 |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
28.5 |
% |
10.1016/j.bmcl.2006.02.021 |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
92.0 |
% |
10.1007/s00044-009-9168-x |
| Homo sapiens |
Cyclooxygenase-2 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2017.02.076 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
501.19 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
7943.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
25118.86 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
39810.72 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Fibroblast |
Growth Rate |
-1.0 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
-0.87 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.09 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.54 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.59 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.62 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.63 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.68 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast growth factor receptor 3 |
Delta TM |
0.81 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Delta TM |
-0.24 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.2 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.61 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.8 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.9 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HERG |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-10.42 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-0.73 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
HUVEC |
Activity |
nan |
None |
10.1016/j.bmcl.2006.02.021 |
| Homo sapiens |
HUVEC |
Inhibition |
50.0 |
% |
10.1016/j.bmcl.2006.02.021 |
| Homo sapiens |
HUVEC |
LD50 |
100.0 |
uM |
10.1016/j.bmcl.2006.02.021 |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Delta TM |
0.69 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
MIA PaCa-2 |
IC50 |
102000.0 |
nM |
10.1016/j.ejmech.2010.08.019 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Neuropeptide S receptor |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
PC-3 |
FC |
1.036 |
None |
10.1038/nchembio790 |
| Homo sapiens |
Peregrin |
Delta TM |
-3.19 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Peripheral myelin protein 22 |
Potency |
84921.4 |
nM |
None |
| Homo sapiens |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Delta TM |
-0.08 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Thrombopoietin |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Transcription intermediary factor 1-alpha |
Delta TM |
-0.34 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Delta TM |
0.2 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
U2OS |
Growth Rate |
0.67 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.83 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.86 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.95 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.98 |
None |
10.6019/CHEMBL5303304 |
| Influenza A virus |
Nonstructural protein 1 |
Potency |
15848.9 |
nM |
None |
| Mus musculus |
MC9 |
Activity |
nan |
None |
10.1021/jm701467e |
| Mus musculus |
MC9 |
Activity |
nan |
None |
10.1021/jm8009876 |
| Mus musculus |
MC9 |
IC50 |
5.0 |
nM |
10.1021/jm701467e |
| Mus musculus |
MC9 |
Inhibition |
79.0 |
% |
10.1021/jm8009876 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Delta IOP |
0.017 |
mmHg |
10.1021/jm030912m |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Delta IOP |
0.23 |
mmHg |
10.1021/jm030912m |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Delta IOP |
0.25 |
mmHg |
10.1021/jm030912m |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Delta IOP |
0.3 |
mmHg |
10.1021/jm030912m |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Delta IOP |
0.34 |
mmHg |
10.1021/jm030912m |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Delta IOP |
0.41 |
mmHg |
10.1021/jm030912m |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Delta IOP |
0.52 |
mmHg |
10.1021/jm030912m |
| Ovis aries |
Cyclooxygenase-1 |
Activity |
1.3 |
% |
10.1021/acs.jnatprod.9b00538 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
6.0 |
nM |
10.1021/acsmedchemlett.1c00004 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
7.0 |
nM |
10.1016/j.ejmech.2015.02.049 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
8.5 |
nM |
10.1016/j.bmc.2012.03.021 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
10.0 |
nM |
10.1016/j.ejmech.2019.07.016 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
10.0 |
nM |
10.1021/acsmedchemlett.1c00065 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
39.0 |
nM |
10.1021/acs.jnatprod.9b00538 |
| Ovis aries |
Cyclooxygenase-1 |
IC50 |
77.0 |
nM |
10.1016/j.ejmech.2013.12.023 |
| Ovis aries |
Cyclooxygenase-1 |
Inhibition |
32.9 |
% |
10.1016/j.bmcl.2009.11.068 |
| Ovis aries |
Cyclooxygenase-1 |
Inhibition |
34.9 |
% |
10.1007/s00044-011-9746-6 |
| Ovis aries |
Cyclooxygenase-1 |
Inhibition |
36.71 |
% |
10.1007/s00044-011-9834-7 |
| Ovis aries |
Cyclooxygenase-1 |
Inhibition |
90.0 |
% |
10.1021/acs.jnatprod.1c00827 |
| Ovis aries |
Cyclooxygenase-1 |
Inhibition |
95.0 |
% |
10.1016/j.ejmech.2013.12.023 |
| Ovis aries |
Cyclooxygenase-1 |
Inhibition |
97.31 |
% |
10.1016/j.bmcl.2017.02.076 |
| Ovis aries |
Cyclooxygenase-1 |
Inhibition |
100.0 |
% |
10.1016/j.bmc.2014.12.041 |
| Ovis aries |
Cyclooxygenase-2 |
IC50 |
74900.0 |
nM |
10.1016/j.ejmech.2015.02.049 |
| Ovis aries |
Cyclooxygenase-2 |
Inhibition |
2.0 |
% |
10.1016/j.ejmech.2013.12.023 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
10000.0 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12589.25 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
18526.0 |
nM |
None |
| Rattus norvegicus |
Cyclooxygenase |
Inhibition |
79.0 |
% |
10.1021/acs.jmedchem.7b00475 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
5623.4 |
nM |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
17782.8 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
37685.8 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
10.4 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
15.63 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
33000.0 |
nM |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 relative |
275.0 |
uM |
10.6019/EOS300033 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
5.8 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
8.66 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
11.67 |
% |
10.6019/CHEMBL4495565 |
| None |
ADMET |
Selectivity index |
0.12 |
None |
10.6019/CHEMBL4495565 |
| None |
NON-PROTEIN TARGET |
IC50 |
5600.0 |
nM |
10.1016/j.ejmech.2010.08.019 |
| None |
NON-PROTEIN TARGET |
Potency |
10000.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
11220.2 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.7b00475 |
| None |
Unchecked |
Inhibition |
10.0 |
% |
10.1021/acs.jmedchem.7b00475 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Potency |
1412.5 |
nM |
None |
| None |
Unchecked |
Potency |
6309.6 |
nM |
None |
| None |
Unchecked |
Ratio IC50 |
0.003 |
None |
10.1016/j.ejmech.2019.07.016 |
| None |
Unchecked |
Ratio IC50 |
179.5 |
None |
10.1021/acsmedchemlett.1c00004 |
| None |
Unchecked |
Ratio IC50 |
5560.0 |
None |
10.1021/acsmedchemlett.1c00065 |